Cadence Pharmaceuticals™

Press Releases

 
All Releases
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
Sep 29, 2008
PDF 10.2 KB
View Summary Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
Sep 15, 2008
PDF 12.9 KB
View Summary Cadence Pharmaceuticals Appoints Todd Rich, M.D. to its Board of Directors and Names Malcolm Lloyd-Smith as Senior Vice President, Regulatory Affairs and Quality Assurance
Aug 28, 2008
PDF 13.9 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
Aug 27, 2008
PDF 10.2 KB
View Summary Cadence Pharmaceuticals Reports Second Quarter 2008 Financial Results and Provides Overview of Clinical Programs
Aug 7, 2008
PDF 18.0 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
Aug 4, 2008
PDF 10.4 KB
View Summary Cadence Pharmaceuticals Announces FDA Concurrence With Clinical Development Plan for Acetavance(TM)
Jul 30, 2008
PDF 14.2 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
Jul 28, 2008
PDF 10.5 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
Jun 17, 2008
PDF 10.2 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
Jun 4, 2008
PDF 10.3 KB
View Summary Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
May 6, 2008
PDF 20.7 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
Apr 30, 2008
PDF 10.5 KB
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008
Apr 30, 2008
PDF 10.6 KB
View Summary Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Mar 13, 2008
PDF 10.3 KB
View Summary Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
Mar 12, 2008
PDF 20.9 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
Mar 6, 2008
PDF 10.5 KB
View Summary Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
Feb 20, 2008
PDF 12.1 KB
View Summary Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Feb 15, 2008
PDF 10.0 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
Jan 31, 2008
PDF 10.2 KB
View Summary Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
Jan 11, 2008
PDF 17.4 KB
Showing 1-20 of 66 releases Page: 1 2 3 4  See Next 20
Print page Print
Email page Email


Stock Quote
CADX - (NASD)
$8.00   - 0.19
Oct 6, 2008
10:31 AM ET

Quotes delayed at
least 20 minutes.
Information provided
by TurboFeed.